|
1
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: Irritable Bowel Syndrome: Diagnosis, Pathogenesis and
Treatment Options. Nova Science Publishers Inc.; New York, NY:
2012
|
|
2
|
Thompson WG: A world view of IBS.
Irritable bowel syndrome. Camilleri M and Spiller RC: Saunders;
Philadelphia and London: pp. 17–26. 2002
|
|
3
|
Agréus L, Svärdsudd K, Nyrén O and Tibblin
G: Irritable bowel syndrome and dyspepsia in the general
population: Overlap and lack of stability over time.
Gastroenterology. 109:671–680. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thompson WG, Irvine EJ, Pare P, Ferrazzi S
and Rance L: Functional gastrointestinal disorders in Canada: First
population-based survey using Rome II criteria with suggestions for
improving the questionnaire. Dig Dis Sci. 47:225–235. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kennedy TM, Jones RH, Hungin AP,
O'flanagan H and Kelly P: Irritable bowel syndrome,
gastro-oesophageal reflux, and bronchial hyper-responsiveness in
the general population. Gut. 43:770–774. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Drossman DA, Li Z, Andruzzi E, Temple RD,
Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P,
Corazziari E, et al: U.S. householder survey of functional
gastro-intestinal disorders. Prevalence, sociodemography, and
health impact. Dig Dis Sci. 38:1569–1580. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talley NJ, Gabriel SE, Harmsen WS,
Zinsmeister AR and Evans RW: Medical costs in community subjects
with irritable bowel syndrome. Gastroenterology. 109:1736–1741.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hungin AP, Whorwell PJ, Tack J and Mearin
F: The prevalence, patterns and impact of irritable bowel syndrome:
An international survey of 40,000 subjects. Aliment Pharmacol Ther.
17:643–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones R and Lydeard S: Irritable bowel
syndrome in the general population. BMJ. 304:87–90. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bordie AK: Functional disorders of the
colon. J Indian Med Assoc. 58:451–456. 1972.PubMed/NCBI
|
|
11
|
O'Keefe EA, Talley NJ, Zinsmeister AR and
Jacobsen SJ: Bowel disorders impair functional status and quality
of life in the elderly: A population-based study. J Gerontol A Biol
Sci Med Sci. 50:M184–M189. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Everhart JE and Renault PF: Irritable
bowel syndrome in office-based practice in the United States.
Gastroenterology. 100:998–1005. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wilson S, Roberts L, Roalfe A, Bridge P
and Singh S: Prevalence of irritable bowel syndrome: A community
survey. Br J Gen Pract. 54:495–502. 2004.PubMed/NCBI
|
|
14
|
Quigley EM, Locke GR, Mueller-Lissner S,
Paulo LG, Tytgat GN, Helfrich I and Schaefer E: Prevalence and
management of abdominal cramping and pain: A multinational survey.
Aliment Pharmacol Ther. 24:411–419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harvey RF, Salih SY and Read AE: Organic
and functional disorders in 2000 gastroenterology outpatients.
Lancet. 1:632–634. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Spiller R, Aziz Q, Creed F, Emmanuel A,
Houghton L, Hungin P, Jones R, Kumar D, Rubin G, Trudgill N, et al
Clinical Services Committee of The British Society of
Gastroenterology: Guidelines on the irritable bowel syndrome:
Mechanisms and practical management. Gut. 56:1770–1798. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorders.
Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thompson WG and Heaton KW: Functional
bowel disorders in apparently healthy people. Gastroenterology.
79:283–288. 1980.PubMed/NCBI
|
|
19
|
Miller V, Whitaker K, Morris JA and
Whorwell PJ: Gender and irritable bowel syndrome: The male
connection. J Clin Gastroenterol. 38:558–560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Whitehead WE, Burnett CK, Cook EW III and
Taub E: Impact of irritable bowel syndrome on quality of life. Dig
Dis Sci. 41:2248–2253. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gralnek IM, Hays RD, Kilbourne A, Naliboff
B and Mayer EA: The impact of irritable bowel syndrome on
health-related quality of life. Gastroenterology. 119:654–660.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
El-Salhy M: Irritable bowel syndrome:
Diagnosis and pathogenesis. World J Gastroenterol. 18:5151–5163.
2012.PubMed/NCBI
|
|
23
|
Chutkan R, Fahey G, Wright WL and McRorie
J: Viscous versus nonviscous soluble fiber supplements: Mechanisms
and evidence for fiber-specific health benefits. J Am Acad Nurse
Pract. 24:476–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bouchoucha M, Faye A, Savarieau B and
Arsac M: Effect of an oral bulking agent and a rectal laxative
administered alone or in combination for the treatment of
constipation. Gastroenterol Clin Biol. 28:438–443. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramkumar D and Rao SS: Efficacy and safety
of traditional medical therapies for chronic constipation:
Systematic review. Am J Gastroenterol. 100:936–971. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McRorie JW, Daggy BP, Morel JG, Diersing
PS, Miner PB and Robinson M: Psyllium is superior to docusate
sodium for treatment of chronic constipation. Aliment Pharmacol
Ther. 12:491–497. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mehmood MH, Aziz N, Ghayur MN and Gilani
AH: Pharmacological basis for the medicinal use of psyllium husk
(Ispaghula) in constipation and diarrhea. Dig Dis Sci.
56:1460–1471. 2011. View Article : Google Scholar
|
|
28
|
Washington N, Harris M, Mussellwhite A and
Spiller RC: Moderation of lactulose-induced diarrhea by psyllium:
Effects on motility and fermentation. Am J Clin Nutr. 67:317–321.
1998.PubMed/NCBI
|
|
29
|
Wenzl HH, Fine KD, Schiller LR and
Fordtran JS: Determinants of decreased fecal consistency in
patients with diarrhea. Gastroenterology. 108:1729–1738. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qvitzau S, Matzen P and Madsen P:
Treatment of chronic diarrhoea: Loperamide versus ispaghula husk
and calcium. Scand J Gastroenterol. 23:1237–1240. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eherer AJ, Santa Ana CA, Porter J and
Fordtran JS: Effect of psyllium, calcium polycarbophil, and wheat
bran on secretory diarrhea induced by phenolphthalein.
Gastroenterology. 104:1007–1012. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Murphy J, Stacey D, Crook J, Thompson B
and Panetta D: Testing control of radiation-induced diarrhea with a
psyllium bulking agent: a pilot study. Can Oncol Nurs J. 10:96–100.
2000. View Article : Google Scholar
|
|
33
|
Sherman DS and Fish DN: Management of
protease inhibitor-associated diarrhea. Clin Infect Dis.
30:908–914. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fernández-Bañares F, Hinojosa J,
Sánchez-Lombraña JL, Navarro E, Martínez-Salmerón JF, García-Pugés
A, González- Huix F, Riera J, González-Lara V, Domínguez-Abascal F,
et al Spanish Group for the Study of Crohn's Disease and Ulcerative
Colitis (GETECCU): Randomized clinical trial of Plantago ovata
seeds (dietary fiber) as compared with mesalamine in maintaining
remission in ulcerative colitis. Am J Gastroenterol. 94:427–433.
1999. View Article : Google Scholar
|
|
35
|
Fujimori S, Gudis K, Mitsui K, Seo T,
Yonezawa M, Tanaka S, Tatsuguchi A and Sakamoto C: A randomized
controlled trial on the efficacy of synbiotic versus probiotic or
prebiotic treatment to improve the quality of life in patients with
ulcerative colitis. Nutrition. 25:520–525. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fujimori S, Tatsuguchi A, Gudis K, Kishida
T, Mitsui K, Ehara A, Kobayashi T, Sekita Y, Seo T and Sakamoto C:
High dose probiotic and prebiotic cotherapy for remission induction
of active Crohn's disease. J Gastroenterol Hepatol. 22:1199–1204.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Smalley JR, Klish WJ, Campbell MA and
Brown MR: Use of psyllium in the management of chronic nonspecific
diarrhea of childhood. J Pediatr Gastroenterol Nutr. 1:361–363.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Heather DJ, Howell L, Montana M, Howell M
and Hill R: Effect of a bulk-forming cathartic on diarrhea in
tube-fed patients. Heart Lung. 20:409–413. 1991.PubMed/NCBI
|
|
39
|
Ford AC, Talley NJ, Spiegel BM,
Foxx-Orenstein AE, Schiller L, Quigley EM and Moayyedi P: Effect of
fibre, antispasmodics, and peppermint oil in the treatment of
irritable bowel syndrome: Systematic review and meta-analysis. BMJ.
337:a23132008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Francis CY and Whorwell PJ: Bran and
irritable bowel syndrome: Time for reappraisal. Lancet. 344:39–40.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bijkerk CJ, de Wit NJ, Muris JW, Whorwell
PJ, Knottnerus JA and Hoes AW: Soluble or insoluble fibre in
irritable bowel syndrome in primary care? Randomised placebo
controlled trial. BMJ. 339:b31542009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Philpott H, Nandurkar S, Lubel J and
Gibson PR: Food, fibre, bile acids and the pelvic floor: An
integrated low risk low cost approach to managing irritable bowel
syndrome. World J Gastroenterol. 21:11379–11386. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nagarajan N, Morden A, Bischof D, King EA,
Kosztowski M, Wick EC and Stein EM: The role of fiber
supplementation in the treatment of irritable bowel syndrome: A
systematic review and meta-analysis. Eur J Gastroenterol Hepatol.
27:1002–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rao SS, Yu S and Fedewa A: Systematic
review: Dietary fibre and FODMAP-restricted diet in the management
of constipation and irritable bowel syndrome. Aliment Pharmacol
Ther. 41:1256–1270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ford AC, Moayyedi P, Lacy BE, Lembo AJ,
Saito YA, Schiller LR, Soffer EE, Spiegel BM and Quigley EM; Task
Force on the Management of Functional Bowel Disorders: American
College of Gastroenterology monograph on the management of
irritable bowel syndrome and chronic idiopathic constipation. Am J
Gastroenterol. 109(Suppl 1): S2–26; quiz S27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moayyedi P, Quigley EM, Lacy BE, Lembo AJ,
Saito YA, Schiller LR, Soffer EE, Spiegel BM and Ford AC: The
effect of fiber supplementation on irritable bowel syndrome: A
systematic review and meta-analysis. Am J Gastroenterol.
109:1367–1374. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Anderson JW, Baird P, Davis RH Jr, Ferreri
S, Knudtson M, Koraym A, Waters V and Williams CL: Health benefits
of dietary fiber. Nutr Rev. 67:188–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dikeman CL and Fahey GC Jr: Viscosity as
related to dietary fiber: A review. Crit Rev Food Sci Nutr.
46:649–663. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Heizer WD, Southern S and McGovern S: The
role of diet in symptoms of irritable bowel syndrome in adults: A
narrative review. J Am Diet Assoc. 109:1204–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chouinard LE: The role of psyllium fibre
supplementation in treating irritable bowel syndrome. Can J Diet
Pract Res. 72:e107–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bijkerk CJ, Muris JW, Knottnerus JA, Hoes
AW and de Wit NJ: Systematic review: The role of different types of
fibre in the treatment of irritable bowel syndrome. Aliment
Pharmacol Ther. 19:245–251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Biesiekierski JR, Rosella O, Rose R, Liels
K, Barrett JS, Shepherd SJ, Gibson PR and Muir JG: Quantification
of fructans, galacto-oligosacharides and other short-chain
carbohydrates in processed grains and cereals. J Hum Nutr Diet.
24:154–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Muir JG, Rose R, Rosella O, Liels K,
Barrett JS, Shepherd SJ and Gibson PR: Measurement of short-chain
carbohydrates in common Australian vegetables and fruits by
high-performance liquid chromatography (HPLC). J Agric Food Chem.
57:554–565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Eswaran S, Muir J and Chey WD: Fiber and
functional gastrointestinal disorders. Am J Gastroenterol.
108:718–727. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
McRorie J, Kesler J, Bishop L, Filloon T,
Allgood G, Sutton M, Hunt T, Laurent A and Rudolph C: Effects of
wheat bran and Olestra on objective measures of stool and
subjective reports of GI symptoms. Am J Gastroenterol.
95:1244–1252. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tomlin J and Read NW: Laxative properties
of indigestible plastic particles. BMJ. 297:1175–1176. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Riottot M, Sacquet E and Leprince C:
Effect of wheat bran upon gastro-intestinal transit in germ-free
and conventional rats. Digestion. 29:37–41. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Burkitt DP, Walker AR and Painter NS:
Effect of dietary fibre on stools and the transit-times, and its
role in the causation of disease. Lancet. 2:1408–1412. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lewis SJ and Heaton KW: Roughage
revisited: The effect on intestinal function of inert plastic
particles of different sizes and shape. Dig Dis Sci. 44:744–748.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lewis SJ and Heaton KW: The intestinal
effects of bran-like plastic particles: Is the concept of
'roughage' valid after all? Eur J Gastroenterol Hepatol. 9:553–557.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Stephen AM and Cummings JH: Mechanism of
action of dietary fibre in the human colon. Nature. 284:283–284.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Stephen AM and Cummings JH: Water holding
by dietary fibre in vitro and its relationship to faecal bulking in
man. Proc Nutr Soc. 38:55A1979.PubMed/NCBI
|
|
63
|
Cummings JH and Stephen AM: The role of
dietary fibre in the human colon. Can Med Assoc J. 123:1109–1114.
1980.PubMed/NCBI
|
|
64
|
Camilleri M: Management of the irritable
bowel syndrome. Gastroenterology. 120:652–668. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Camilleri M and Katzka DA: Irritable bowel
syndrome: Methods, mechanisms, and pathophysiology. Genetic
epidemiology and pharmacogenetics in irritable bowel syndrome. Am J
Physiol Gastrointest Liver Physiol. 302:G1075–G1084. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Camilleri M, Heading RC and Thompson WG:
Clinical perspectives, mechanisms, diagnosis and management of
irritable bowel syndrome. Aliment Pharmacol Ther. 16:1407–1430.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Gonlachanvit S, Coleski R, Owyang C and
Hasler W: Inhibitory actions of a high fibre diet on intestinal gas
transit in healthy volunteers. Gut. 53:1577–1582. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Hamer HM, Jonkers D, Venema K, Vanhoutvin
S, Troost FJ and Brummer RJ: Review article: The role of butyrate
on colonic function. Aliment Pharmacol Ther. 27:104–119. 2008.
View Article : Google Scholar
|
|
69
|
Hamer HM, Jonkers DM, Bast A, Vanhoutvin
SA, Fischer MA, Kodde A, Troost FJ, Venema K and Brummer RJ:
Butyrate modulates oxidative stress in the colonic mucosa of
healthy humans. Clin Nutr. 28:88–93. 2009. View Article : Google Scholar
|
|
70
|
Hamer HM, Jonkers DM, Loof A, Vanhoutvin
SA, Troost FJ, Venema K, Kodde A, Koek GH, Schipper RG, van Heerde
WL, et al: Analyses of human colonic mucus obtained by an in vivo
sampling technique. Dig Liver Dis. 41:559–564. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hamer HM, Jonkers DM, Renes IB, Vanhoutvin
SA, Kodde A, Troost FJ, Venema K and Brummer RJ: Butyrate enemas do
not affect human colonic MUC2 and TFF3 expression. Eur J
Gastroenterol Hepatol. 22:1134–1140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Hamer HM, Jonkers DM, Vanhoutvin SA,
Troost FJ, Rijkers G, de Bruïne A, Bast A, Venema K and Brummer RJ:
Effect of butyrate enemas on inflammation and antioxidant status in
the colonic mucosa of patients with ulcerative colitis in
remission. Clin Nutr. 29:738–744. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Keszthelyi D, Troost FJ, Jonkers DM,
Helyes Z, Hamer HM, Ludidi S, Vanhoutvin S, Venema K, Dekker J,
Szolcsányi J, et al: Alterations in mucosal neuropeptides in
patients with irritable bowel syndrome and ulcerative colitis in
remission: A role in pain symptom generation? Eur J Pain.
17:1299–1306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Vanhoutvin SA, Troost FJ, Hamer HM,
Lindsey PJ, Koek GH, Jonkers DM, Kodde A, Venema K and Brummer RJ:
Butyrate-induced transcriptional changes in human colonic mucosa.
PLoS One. 4:e67592009. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Vanhoutvin SA, Troost FJ, Kilkens TO,
Lindsey PJ, Hamer HM, Jonkers DM, Venema K and Brummer RJ: The
effects of butyrate enemas on visceral perception in healthy
volunteers. Neurogastroenterol Motil. 21:952–e76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
McRorie J, Pepple S and Rudolph C: Effects
of fiber laxatives and calcium docusate on regional water content
and viscosity of digesta in the large intestine of the pig. Dig Dis
Sci. 43:738–745. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Marlett JA and Fischer MH: The active
fraction of psyllium seed husk. Proc Nutr Soc. 62:207–209. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Marlett JA, Kajs TM and Fischer MH: An
unfermented gel component of psyllium seed husk promotes laxation
as a lubricant in humans. Am J Clin Nutr. 72:784–789.
2000.PubMed/NCBI
|
|
79
|
Fischer MH, Yu N, Gray GR, Ralph J,
Anderson L and Marlett JA: The gel-forming polysaccharide of
psyllium husk (Plantago ovata Forsk). Carbohydr Res. 339:2009–2017.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Gibson GR, Probert HM, Loo JV, Rastall RA
and Roberfroid MB: Dietary modulation of the human colonic
microbiota: Updating the concept of prebiotics. Nutr Res Rev.
17:259–275. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Gibson GR and Roberfroid MB: Dietary
modulation of the human colonic microbiota: Introducing the concept
of prebiotics. J Nutr. 125:1401–1412. 1995.PubMed/NCBI
|
|
82
|
Roberfroid M: Prebiotics: The concept
revisited. J Nutr. 137(Suppl 2): 830S–837S. 2007.PubMed/NCBI
|
|
83
|
Roberfroid M, Gibson GR, Hoyles L,
McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska
H, Stahl B, et al: Prebiotic effects: Metabolic and health
benefits. Br J Nutr. 104(Suppl 2): S1–S63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gibson GR, Beatty ER, Wang X and Cummings
JH: Selective stimulation of bifidobacteria in the human colon by
oligofructose and inulin. Gastroenterology. 108:975–982. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Bouhnik Y, Flourié B, Riottot M, Bisetti
N, Gailing MF, Guibert A, Bornet F and Rambaud JC: Effects of
fructooligosaccharides ingestion on fecal bifidobacteria and
selected metabolic indexes of colon carcinogenesis in healthy
humans. Nutr Cancer. 26:21–29. 1996. View Article : Google Scholar
|
|
86
|
Bouhnik Y, Raskine L, Simoneau G, Paineau
D and Bornet F: The capacity of short-chain fructo-oligosaccharides
to stimulate faecal bifidobacteria: A dose-response relationship
study in healthy humans. Nutr J. 5:82006. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Bouhnik Y, Vahedi K, Achour L, Attar A,
Salfati J, Pochart P, Marteau P, Flourié B, Bornet F and Rambaud
JC: Short-chain fructo-oligosaccharide administration
dose-dependently increases fecal bifidobacteria in healthy humans.
J Nutr. 129:113–116. 1999.PubMed/NCBI
|
|
88
|
Kleessen B, Sykura B, Zunft HJ and Blaut
M: Effects of inulin and lactose on fecal microflora, microbial
activity, and bowel habit in elderly constipated persons. Am J Clin
Nutr. 65:1397–1402. 1997.PubMed/NCBI
|
|
89
|
Zimmerman MA, Singh N, Martin PM,
Thangaraju M, Ganapathy V, Waller JL, Shi H, Robertson KD, Munn DH
and Liu K: Butyrate suppresses colonic inflammation through
HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T
cells. Am J Physiol Gastrointest Liver Physiol. 302:G1405–G1415.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Klampfer L, Huang J, Sasazuki T, Shirasawa
S and Augenlicht L: Inhibition of interferon gamma signaling by the
short chain fatty acid butyrate. Mol Cancer Res. 1:855–862.
2003.PubMed/NCBI
|
|
91
|
Stempelj M, Kedinger M, Augenlicht L and
Klampfer L: Essential role of the JAK/STAT1 signaling pathway in
the expression of inducible nitric-oxide synthase in intestinal
epithelial cells and its regulation by butyrate. J Biol Chem.
282:9797–9804. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
May CL and Kaestner KH: Gut endocrine cell
development. Mol Cell Endocrinol. 323:70–75. 2010. View Article : Google Scholar :
|
|
93
|
Gunawardene AR, Corfe BM and Staton CA:
Classification and functions of enteroendocrine cells of the lower
gastrointestinal tract. Int J Exp Pathol. 92:219–231. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
El-Salhy M, Ostgaard H, Gundersen D,
Hatlebakk JG and Hausken T: The role of diet in the pathogenesis
and management of irritable bowel syndrome (Review). Int J Mol Med.
29:723–731. 2012.PubMed/NCBI
|
|
95
|
El-Salhy M, Seim I, Chopin L, Gundersen D,
Hatlebakk JG and Hausken T: Irritable bowel syndrome: The role of
gut neuroendocrine peptides. Front Biosci (Elite Ed). 4:2783–2800.
2012.
|
|
96
|
Tanaka-Shintani M and Watanabe M:
Immunohistochemical study of enterochromaffin-like cell in human
gastric mucosa. Pathol Int. 57:572–583. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Lönroth H, Håkanson R, Lundell L and
Sundler F: Histamine containing endocrine cells in the human
stomach. Gut. 31:383–388. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Buffa R, Capella C, Fontana P, Usellini L
and Solcia E: Types of endocrine cells in the human colon and
rectum. Cell Tissue Res. 192:227–240. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Schonhoff SE, Giel-Moloney M and Leiter
AB: Minireview: Development and differentiation of gut endocrine
cells. Endocrinology. 145:2639–2644. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Sjölund K, Sandén G, Håkanson R and
Sundler F: Endocrine cells in human intestine: An
immunocytochemical study. Gastroenterology. 85:1120–1130.
1983.PubMed/NCBI
|
|
101
|
Sandström O and El-Salhy M: Ageing and
endocrine cells of human duodenum. Mech Ageing Dev. 108:39–48.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
El-Salhy M: Ghrelin in gastrointestinal
diseases and disorders: A possible role in the pathophysiology and
clinical implications (Review). Int J Mol Med. 24:727–732. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Tolhurst G, Reimann F and Gribble FM:
Intestinal sensing of nutrients. Handb Exp Pharmacol. 209:309–335.
2012. View Article : Google Scholar
|
|
104
|
Lee J, Cummings BP, Martin E, Sharp JW,
Graham JL, Stanhope KL, Havel PJ and Raybould HE: Glucose sensing
by gut endocrine cells and activation of the vagal afferent pathway
is impaired in a rodent model of type 2 diabetes mellitus. Am J
Physiol Regul Integr Comp Physiol. 302:R657–R666. 2012. View Article : Google Scholar
|
|
105
|
Parker HE, Reimann F and Gribble FM:
Molecular mechanisms underlying nutrient-stimulated incretin
secretion. Expert Rev Mol Med. 12:e12010. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Raybould HE: Nutrient sensing in the
gastrointestinal tract: Possible role for nutrient transporters. J
Physiol Biochem. 64:349–356. 2008. View Article : Google Scholar
|
|
107
|
San Gabriel A, Nakamura E, Uneyama H and
Torii K: Taste, visceral information and exocrine reflexes with
glutamate through umami receptors. J Med Invest. 56(Suppl):
209–217. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Rudholm T, Wallin B, Theodorsson E,
Näslund E and Hellström PM: Release of regulatory gut peptides
somatostatin, neurotensin and vasoactive intestinal peptide by acid
and hyperosmolal solutions in the intestine in conscious rats.
Regul Pept. 152:8–12. 2009. View Article : Google Scholar
|
|
109
|
Sternini C, Anselmi L and Rozengurt E:
Enteroendocrine cells: A site of 'taste' in gastrointestinal
chemosensing. Curr Opin Endocrinol Diabetes Obes. 15:73–78. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Sternini C: Taste receptors in the
gastrointestinal tract. IV. Functional implications of bitter taste
receptors in gastrointestinal chemosensing. Am J Physiol
Gastrointest Liver Physiol. 292:G457–G461. 2007. View Article : Google Scholar
|
|
111
|
Buchan AM: Nutrient Tasting and Signaling
Mechanisms in the Gut III. Endocrine cell recognition of luminal
nutrients. Am J Physiol. 277:G1103–G1107. 1999.PubMed/NCBI
|
|
112
|
Montero-Hadjadje M, Elias S, Chevalier L,
Benard M, Tanguy Y, Turquier V, Galas L, Yon L, Malagon MM,
Driouich A, et al: Chromogranin A promotes peptide hormone sorting
to mobile granules in constitutively and regulated secreting cells:
Role of conserved N- and C-terminal peptides. J Biol Chem.
284:12420–12431. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Shooshtarizadeh P, Zhang D, Chich JF,
Gasnier C, Schneider F, Haïkel Y, Aunis D and Metz-Boutigue MH: The
antimicrobial peptides derived from chromogranin/secretogranin
family, new actors of innate immunity. Regul Pept. 165:102–110.
2010. View Article : Google Scholar
|
|
114
|
El-Salhy M, Gundersen D, Gilja OH,
Hatlebakk JG and Hausken T: Is irritable bowel syndrome an organic
disorder? World J Gastroenterol. 20:384–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
El-Salhy M, Hatlebakk JG, Gilja OH and
Hausken T: Irritable bowel syndrome: Recent developments in
diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol
Hepatol. 8:435–443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Rindi G, Inzani F and Solcia E: Pathology
of gastrointestinal disorders. Endocrinol Metab Clin North Am.
39:713–727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Seim I, El-Salhy M, Hausken T, Gundersen D
and Chopin L: Ghrelin and the brain-gut axis as a pharmacological
target for appetite control. Curr Pharm Des. 18:768–775. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Gershon MD: 5-Hydroxytryptamine
(serotonin) in the gastrointestinal tract. Curr Opin Endocrinol
Diabetes Obes. 20:14–21. 2013. View Article : Google Scholar :
|
|
119
|
Holzer P and Farzi A: Neuropeptides and
the microbiota-gut-brain axis. Adv Exp Med Biol. 817:195–219. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Cani PD, Everard A and Duparc T: Gut
microbiota, enteroendocrine functions and metabolism. Curr Opin
Pharmacol. 13:935–940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Everard A and Cani PD: Gut microbiota and
GLP-1. Rev Endocr Metab Disord. 15:189–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Arora T, Loo RL, Anastasovska J, Gibson
GR, Tuohy KM, Sharma RK, Swann JR, Deaville ER, Sleeth ML, Thomas
EL, et al: Differential effects of two fermentable carbohydrates on
central appetite regulation and body composition. PLoS One.
7:e432632012. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Maljaars PW, Keszthelyi D and Masclee AA:
An ileal brake-through? Am J Clin Nutr. 92:467–468. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Van Citters GW and Lin HC: Ileal brake:
Neuropeptidergic control of intestinal transit. Curr Gastroenterol
Rep. 8:367–373. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Lin HC, Zhao XT, Wang L and Wong H:
Fat-induced ileal brake in the dog depends on peptide YY.
Gastroenterology. 110:1491–1495. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Pironi L, Stanghellini V, Miglioli M,
Corinaldesi R, De Giorgio R, Ruggeri E, Tosetti C, Poggioli G,
Morselli Labate AM, Monetti N, et al: Fat-induced ileal brake in
humans: A dose-dependent phenomenon correlated to the plasma levels
of peptide YY. Gastroenterology. 105:733–739. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Spiller RC, Trotman IF, Adrian TE, Bloom
SR, Misiewicz JJ and Silk DB: Further characterisation of the
'ileal brake' reflex in man - effect of ileal infusion of partial
digests of fat, protein, and starch on jejunal motility and release
of neurotensin, enteroglucagon, and peptide YY. Gut. 29:1042–1051.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Spiller RC, Trotman IF, Higgins BE, Ghatei
MA, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ and Silk DB: The
ileal brake - inhibition of jejunal motility after ileal fat
perfusion in man. Gut. 25:365–374. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Goumain M, Voisin T, Lorinet AM, Ducroc R,
Tsocas A, Rozé C, Rouet-Benzineb P, Herzog H, Balasubramaniam A and
Laburthe M: The peptide YY-preferring receptor mediating inhibition
of small intestinal secretion is a peripheral Y(2) receptor:
Pharmacological evidence and molecular cloning. Mol Pharmacol.
60:124–134. 2001.PubMed/NCBI
|
|
130
|
Souli A, Chariot J, Voisin T, Presset O,
Tsocas A, Balasubramaniam A, Laburthe M and Rozé C: Several
receptors mediate the antisecretory effect of peptide YY,
neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid
secretion in the rat jejunum in vivo. Peptides. 18:551–557. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Whang EE, Hines OJ, Reeve JR Jr, Grandt D,
Moser JA, Bilchik AJ, Zinner MJ, McFadden DW and Ashley SW:
Antisecretory mechanisms of peptide YY in rat distal colon. Dig Dis
Sci. 42:1121–1127. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Mazzawi T and El-Salhy M: Changes in small
intestinal chro-mogranin A-immunoreactive cell densities in
patients with irritable bowel syndrome after receiving dietary
guidance. Int J Mol Med. 37:1247–1253. 2016.PubMed/NCBI
|
|
133
|
Mazzawi T, Gundersen D, Hausken T and
El-Salhy M: Increased gastric chromogranin A cell density following
changes to diets of patients with irritable bowel syndrome. Mol Med
Rep. 10:2322–2326. 2014.PubMed/NCBI
|
|
134
|
Mazzawi T, Gundersen D, Hausken T and
El-Salhy M: Increased chromogranin A cell density in the large
intestine of patients with irritable bowel syndrome after receiving
dietary guidance. Gastroenterol Res Pract. 2015:8238972015.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Mazzawi T, Hausken T, Gundersen D and
El-Salhy M: Effect of dietary management on the gastric endocrine
cells in patients with irritable bowel syndrome. Eur J Clin Nutr.
69:519–524. 2015. View Article : Google Scholar :
|
|
136
|
Mazzawi T and El-Salhy M: Changes in
duodenal enteroendocrine cells in patients with irritable bowel
syndrome following dietary guidance. Exp Biol Med. 0:1–8. 2017.
View Article : Google Scholar
|
|
137
|
Mazzawi T, Hausken T, Gundersen D and
El-Salhy M: Dietary guidance normalizes large intestinal endocrine
cell densities in patients with irritable bowel syndrome. Eur J
Clin Nutr. 70:175–181. 2016. View Article : Google Scholar :
|
|
138
|
Mazzawi T and El-Salhy M: Dietary guidance
and ileal enteroendocrine cells in patients with irritable bowel
syndrome. Exp Ther Med. 12:1398–1404. 2016.PubMed/NCBI
|
|
139
|
Soret R, Chevalier J, De Coppet P, Poupeau
G, Derkinderen P, Segain JP and Neunlist M: Short-chain fatty acids
regulate the enteric neurons and control gastrointestinal motility
in rats. Gastroenterology. 138:1772–1782. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Bellini M, Gambaccini D, Salvadori S,
Tosetti C, Urbano MT, Costa F, Monicelli P, Mumolo MG, Ricchiuti A,
De Bortoli N, et al: Management of chronic constipation in general
practice. Tech Coloproctol. 18:543–549. 2014.
|
|
141
|
Furnari M, de Bortoli N, Martinucci I,
Bodini G, Revelli M, Marabotto E, Moscatelli A, Del Nero L,
Savarino E, Giannini EG, et al: Optimal management of constipation
associated with irritable bowel syndrome. Ther Clin Risk Manag.
11:691–703. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Alaimo K, McDowell MA, Briefel RR, Bischof
AM, Caughman CR, Loria CM and Johnson CL: Dietary intake of
vitamins, minerals, and fiber of persons ages 2 months and over in
the United States: Third National Health and Nutrition Examination
Survey, Phase 1, 1988–91. Adv Data. 258:1–28. 1994.
|
|
143
|
Briefel RR, Sempos CT, McDowell MA, Chien
S and Alaimo K: Dietary methods research in the third National
Health and Nutrition Examination Survey: Underreporting of energy
intake. Am J Clin Nutr. 65(Suppl 4): 1203S–1209S. 1997.PubMed/NCBI
|
|
144
|
McRorie JW Jr: Evidence-based approach to
fiber supplements and clinically meaningful health benefits, Part
2: What to look for and how to recommend an effective fiber
therapy. Nutr Today. 50:90–97. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
McRorie JW Jr: Evidence-based approach to
fiber supplements and clinically meaningful health benefits, Part
1: What to look for and how to recommend an effective fiber
therapy. Nutr Today. 50:82–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Rutten JM, Korterink JJ, Venmans LM,
Benninga MA and Tabbers MM: Nonpharmacologic treatment of
functional abdominal pain disorders: A systematic review.
Pediatrics. 135:522–535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Shah SL and Lacy BE: Dietary interventions
and irritable bowel dyndrome: A review of the evidence. Curr
Gastroenterol Rep. 18:412016. View Article : Google Scholar
|
|
148
|
Ansari R, Attari F, Razjouyan H, Etemadi
A, Amjadi H, Merat S and Malekzadeh R: Ulcerative colitis and
irritable bowel syndrome: Relationships with quality of life. Eur J
Gastroenterol Hepatol. 20:46–50. 2008. View Article : Google Scholar
|
|
149
|
Ford AC, Chey WD, Talley NJ, Malhotra A,
Spiegel BM and Moayyedi P: Yield of diagnostic tests for celiac
disease in individuals with symptoms suggestive of irritable bowel
syndrome: Systematic review and meta-analysis. Arch Intern Med.
169:651–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Brandt LJ, Prather CM, Quigley EM,
Schiller LR, Schoenfeld P and Talley NJ: Systematic review on the
management of chronic constipation in North America. Am J
Gastroenterol. 100(Suppl 1): S5–S21. 2005. View Article : Google Scholar : PubMed/NCBI
|
